1.Neural cell adhesion molecule (NCAM) promotes the differentiation of hippocampal precursor cells to a neuronal lineage, especially to a glutamatergic neural cell type.
Min Hwa SHIN ; Eu Gene LEE ; Sang Hun LEE ; Yong Sung LEE ; Hyeon SON
Experimental & Molecular Medicine 2002;34(6):401-410
Rat hippocampal precursor cells isolated from hippocampi of embryonic day 16.5 (E16.5) rat embryos were found to proliferate in the presence of basic fibroblast growth factor. Addition of soluble neural cell adhesion molecule (NCAM) to these precursor cells reduced cell proliferation in a dose dependent manner and enhanced the induction of precursor cells' differentiation to the neuronal lineage. Given these findings that NCAM induces the differentiation of hippocampal precursor cells, we investigated possible effects of NCAM on the expression of basic helix-loop-helix (bHLH) transcription factors during the differentiation. Soluble NCAM upregulated the transcription of bHLH transcription factors, neurogenin1 and NeuroD, but decreased HES5. Western blot analysis showed that NCAM increased the expression levels of CaMKII, p-MAPK, GluR1 and NR1 but decreased p-STAT3. These results support a role for NCAM in the inhibition of proliferation and the induction of neural differentiation of hippocampal neural precursor cells, and act as developmental regulators of the bHLH families, ultimately leading to the generation of glutamatergic neural cell types in the differentiation of hippocampal precursor cells.
Animals
;
Apoptosis/drug effects
;
Cell Differentiation/*drug effects
;
Cell Division/drug effects
;
Cell Lineage/drug effects
;
Cells, Cultured
;
Helix-Loop-Helix Motifs
;
Hippocampus/*cytology/*drug effects
;
Neural Cell Adhesion Molecules/*pharmacology
;
Neurons/cytology/*drug effects/metabolism
;
RNA, Messenger/genetics/metabolism
;
Rats
;
Receptors, Glutamate/*metabolism
;
Signal Transduction
;
Stem Cells/cytology/*drug effects
;
Transcription Factors/genetics/metabolism
2.Effect of Qinghuang Powder () Combined with Bupi Yishen Decoction () in Treating Patients with Refractory Cytopenia with Multilineage Dysplasia through Regulating DNA Methylation.
Qing-Bing ZHOU ; Xiao-Hong YANG ; Hong-Zhi WANG ; De-Xiu WANG ; Yong-Gang XU ; Xiao-Mei HU ; Feng-Qin XU ; Rou MA
Chinese journal of integrative medicine 2019;25(5):354-359
OBJECTIVE:
To explore the effect of Qinghuang Powder (QHP,()combined with Bupi Yishen Decoction (BPYS, ) on myelodysplastic syndromes (MDS) patients with refractory cytopenia with multilineage dysplasia (RCMD) and determine the change of DNA methylation in MDS-RCMD patients after the treatment of Chinese medicine formula.
METHODS:
All 308 MDS-RCMD patients were treated with QHP combined with BPYS for 2 months at least, absolute neutrophil count (ANC), hemoglobin (Hb), platelets (PLT), primitive bone marrow cells and chromosome karyotype were chosen as the main evaluation indexes to analyze the treatment effect according to criteria from the MDS International Working Group. Then 43 bone marrow samples from 15 MDS-RCMD patients and 28 healthy donors were obtained for the examination of DNA methylation. Gene Ontology (GO) and Pathway analysis were applied to analyze the methylation data.
RESULTS:
The overall MDS response rate to QHP was 61.68% (190/360) including hematologic improvement-neutrophil (HI-N) or hematologic improvement-erythroid (HI-E) or hematologic improvement-platelet (HI-P). Patients with anemia had a better response rate than patients with neutropenia or thrombocypenia (55.88% vs 31.54% or 55.88% vs. 36.9%). The DNA methylation microarray analysis disclosed that 4,257 hypermethylated genes were demethylated upon the treatment with QHP and BPYS. GO analysis and Pathway analysis showed that these demethylated genes were involved in a lot of tumor-related pathways and functions.
CONCLUSIONS
QHP combined with BPYS could effectively treat MDS-RCMD patients through hematologic improvement (HI-N, HI-P or HI-E) and PLT and RBC transfusion independence due to the demethylation, thereby providing another choice for the treatment of patients with MDS-RCMD.
Arsenicals
;
administration & dosage
;
pharmacology
;
therapeutic use
;
Cell Lineage
;
drug effects
;
DNA Methylation
;
drug effects
;
Demethylation
;
Drugs, Chinese Herbal
;
administration & dosage
;
pharmacology
;
therapeutic use
;
Female
;
Gene Ontology
;
Humans
;
Leukocyte Disorders
;
drug therapy
;
genetics
;
Male
;
Middle Aged
;
Powders
;
Treatment Outcome
3.Reactive oxygen species enhance differentiation of human embryonic stem cells into mesendodermal lineage.
Ae Ri JI ; Seung Yup KU ; Myung Soo CHO ; Yoon Young KIM ; Yong Jin KIM ; Sun Kyung OH ; Seok Hyun KIM ; Shin Yong MOON ; Young Min CHOI
Experimental & Molecular Medicine 2010;42(3):175-186
Recently, reactive oxygen species (ROS) have been studied as a regulator of differentiation into specific cell types in embryonic stem cells (ESCs). However, ROS role in human ESCs (hESCs) is unknown because mouse ESCs have been used mainly for most studies. Herein we suggest that ROS generation may play a critical role in differentiation of hESCs; ROS enhances differentiation of hESCs into bi-potent mesendodermal cell lineage via ROS-involved signaling pathways. In ROS-inducing conditions, expression of pluripotency markers (Oct4, Tra 1-60, Nanog, and Sox2) of hESCs was decreased, while expression of mesodermal and endodermal markers was increased. Moreover, these differentiation events of hESCs in ROS-inducing conditions were decreased by free radical scavenger treatment. hESC-derived embryoid bodies (EBs) also showed similar differentiation patterns by ROS induction. In ROS-related signaling pathway, some of the MAPKs family members in hESCs were also affected by ROS induction. p38 MAPK and AKT (protein kinases B, PKB) were inactivated significantly by buthionine sulfoximine (BSO) treatment. JNK and ERK phosphorylation levels were increased at early time of BSO treatment but not at late time point. Moreover, MAPKs family-specific inhibitors could prevent the mesendodermal differentiation of hESCs by ROS induction. Our results demonstrate that stemness and differentiation of hESCs can be regulated by environmental factors such as ROS.
Biological Markers/metabolism
;
Cell Differentiation/*drug effects
;
Cell Line
;
Cell Lineage/*drug effects
;
Cells, Cultured
;
Down-Regulation/drug effects
;
Embryo, Mammalian/cytology/drug effects/metabolism
;
Embryonic Stem Cells/*cytology/*drug effects/enzymology
;
Endoderm/*cytology/drug effects
;
Enzyme Activation/drug effects
;
Free Radical Scavengers/pharmacology
;
Humans
;
Mesoderm/*cytology/drug effects
;
Mitogen-Activated Protein Kinases/metabolism
;
Pluripotent Stem Cells/cytology/metabolism
;
Reactive Oxygen Species/metabolism/*pharmacology
;
Up-Regulation/drug effects
4.Induced pluripotency and direct reprogramming: a new window for treatment of neurodegenerative diseases.
Rui LI ; Ye BAI ; Tongtong LIU ; Xiaoqun WANG ; Qian WU
Protein & Cell 2013;4(6):415-424
Human embryonic stem cells (hESCs) are pluripotent cells that have the ability of unlimited self-renewal and can be differentiated into different cell lineages, including neural stem (NS) cells. Diverse regulatory signaling pathways of neural stem cells differentiation have been discovered, and this will be of great benefit to uncover the mechanisms of neuronal differentiation in vivo and in vitro. However, the limitations of hESCs resource along with the religious and ethical concerns impede the progress of ESCs application. Therefore, the induced pluripotent stem cells (iPSCs) via somatic cell reprogramming have opened up another new territory for regenerative medicine. iPSCs now can be derived from a number of lineages of cells, and are able to differentiate into certain cell types, including neurons. Patient-specifi c iPSCs are being used in human neurodegenerative disease modeling and drug screening. Furthermore, with the development of somatic direct reprogramming or lineage reprogramming technique, a more effective approach for regenerative medicine could become a complement for iPSCs.
Cell Differentiation
;
Cell Lineage
;
Cell Transdifferentiation
;
Cellular Reprogramming
;
drug effects
;
Embryonic Stem Cells
;
cytology
;
Humans
;
Induced Pluripotent Stem Cells
;
cytology
;
transplantation
;
Neural Stem Cells
;
cytology
;
transplantation
;
Neurodegenerative Diseases
;
therapy
;
Regenerative Medicine
;
Transcription Factors
;
genetics
;
metabolism
5.CKbeta8-1 alters expression of cyclin E in colony forming units-granulocyte macrophage (CFU-GM) lineage from human cord blood CD34 + cells.
Eui Kyu NOH ; Jae Sun RA ; Seong Ae LEE ; Byoung S KWON ; In Seob HAN
Experimental & Molecular Medicine 2005;37(6):619-623
A C6 beta-chemokine, CKbeta8-1, suppressed the colony formation of CD34 + cells of human cord blood (CB). Molecular mechanisms involved in CKbeta8-1-medicated suppression of colony formation of CD34 + cells are not known. To address this issue, the level of various G1/S cell cycle regulating proteins in CKbeta8-1-treated CD34 + cells were compared with those in untreated CD34 + cells. CKbeta8-1 did not significantly alter the expression of the G1/S cycle regulation proteins (cyclin D1, D3, and E), CDK inhibitor (p27and Rb), and other cell proliferation regulation protein (p53) in CB CD34 + cells. Here we describe an in vitro system in which CB CD34 + cells were committed to a multipotent progenitor lineage of colony forming units-granulocyte/macrophage (CFU-GM) by a simple combination of recombinant human (rh) GM-CSF and rhIL-3. In this culture system, we found that cyclin E protein appeared later and disappeared faster in the CKbeta8-1-treated cells than in the control cells during CFU-GM lineage development. These findings suggested that cyclin E may play a role in suppressing the colony formation of CFU-GM by CKbeta8-1.
Antigens, CD34/metabolism
;
Cell Cycle Proteins/metabolism
;
Cell Lineage
;
Cells, Cultured
;
Chemokines, CC/*pharmacology
;
Cyclin E/*metabolism
;
Fetal Blood/*cytology
;
G1 Phase/drug effects
;
Gene Expression Regulation/*drug effects
;
Granulocytes/cytology/*drug effects/metabolism
;
Growth Substances/pharmacology
;
Humans
;
Macrophages/cytology/*drug effects/metabolism
;
Research Support, Non-U.S. Gov't
;
Stem Cells/cytology/*drug effects/metabolism
6.Dynamic roles of angiopoietin-like proteins 1, 2, 3, 4, 6 and 7 in the survival and enhancement of ex vivo expansion of bone-marrow hematopoietic stem cells.
Shahina AKHTER ; Md Mashiar RAHMAN ; Hyun Seo LEE ; Hyeon-Jin KIM ; Seong-Tshool HONG
Protein & Cell 2013;4(3):220-230
Recent advances in hematopoietic stem cells (HSCs) expansion by growth factors including angiopoietin-like proteins (Angptls) have opened up the possibility to use HSCs in regenerative medicine. However, the unavailability of true in vitro HSCs expansion by these growth factors has limited the understanding of the cellular and molecular mechanism of HSCs expansion. Here, we report the functional role of mouse Angptls 1, 2, 3, 4, 6 and 7 and growth factors SCF, TPO, IGF-2 and FGF-1 on purified mouse bone-marrow (BM) Lineage(-)Sca-1(+)(Lin-Sca-1(+)) HSCs. The recombinant retroviral transduced-CHO-S cells that secrete Angptls in serum-free medium were used alone or in combination with growth factors (SCF, TPO, IGF-2 and FGF-1). None of the Angptls stimulated HSC proliferation, enhanced or inhibited HSCs colony formation, but they did support the survival of HSCs. By contrast, any of the six Angptls together with saturating levels of growth factors dramatically stimulated a 3- to 4.5-fold net expansion of HSCs compared to stimulation with a combination of those growth factors alone. These findings lead to an understanding of the basic function of Angptls on signaling pathways for the survival as well as expansion of HSCs in the bone marrow niche.
Angiopoietin-like 4 Protein
;
Angiopoietin-like Proteins
;
Angiopoietins
;
genetics
;
metabolism
;
Animals
;
Antigens, Ly
;
metabolism
;
Bone Marrow Cells
;
cytology
;
CHO Cells
;
Cell Differentiation
;
drug effects
;
Cell Lineage
;
Cell Proliferation
;
drug effects
;
Cell Survival
;
drug effects
;
Cells, Cultured
;
Cricetinae
;
Cricetulus
;
Culture Media, Conditioned
;
pharmacology
;
Hematopoietic Stem Cells
;
cytology
;
metabolism
;
Intercellular Signaling Peptides and Proteins
;
pharmacology
;
Membrane Proteins
;
metabolism
;
Mice
;
Transfection
7.Initial division behavior of cord blood hematopoietic stem cells depends on microenvironment.
Daihong LIU ; M PUNZEL ; Ad HO
Chinese Journal of Hematology 2002;23(10):534-537
OBJECTIVEThe influence of the mimic hematopoietic microenvironment and adhesion factor on the initial divisional behavior of human cord blood hematopoietic progenitors was studied in the culture system with certain cytokines.
METHODS(1) CD(34)(+) CD(38)(-) single cell was sorted by FACS. (2) The stem cell supporting stromal feeder layer AFT024 and single adhesive factor fibronectin (Fn) were used in the culture system and their influence on the initial division was observed.
RESULTS(1) In the presence of the combined cytokines, the CD(34)(+) CD(38)(-) human cord blood cells displayed fixed fraction of quiescent, slow and fast division, and asymmetric division. (2) There was no influence of adhesive factor itself on initial division of CD(34)(+) CD(38)(-) cells. (3) The hematopoietic microenvironment mimicked by AFT024 promoted CD(34)(+) CD(38)(-) cells to proliferate extensively and undergo more asymmetric division.
CONCLUSIONS(1) CD(34)(+) CD(38)(-) cells are heterogeneous and composed of various subpopulations with different initial proliferative behavior, including asymmetric division. (2) The hematopoietic microenvironmental mimicked by AFT024 supports the hematopoietic progenitors better than cytokines and single adhesion factor do, for their proliferation extensively and preservation the self-renewal capacity.
ADP-ribosyl Cyclase ; analysis ; ADP-ribosyl Cyclase 1 ; Antigens, CD ; analysis ; Antigens, CD34 ; analysis ; Cell Division ; drug effects ; Cell Lineage ; drug effects ; immunology ; physiology ; Cytokines ; pharmacology ; Fetal Blood ; cytology ; drug effects ; immunology ; Fibronectins ; pharmacology ; Flow Cytometry ; Hematopoietic Stem Cells ; cytology ; drug effects ; immunology ; Humans ; Infant, Newborn ; Membrane Glycoproteins ; Stromal Cells ; physiology
8.The similarity between human embryonic stem cell-derived epithelial cells and ameloblast-lineage cells.
Li-Wei ZHENG ; Logan LINTHICUM ; Pamela K DENBESTEN ; Yan ZHANG
International Journal of Oral Science 2013;5(1):1-6
This study aimed to compare epithelial cells derived from human embryonic stem cells (hESCs) to human ameloblast-lineage cells (ALCs), as a way to determine their potential use as a cell source for ameloblast regeneration. Induced by various concentrations of bone morphogenetic protein 4 (BMP4), retinoic acid (RA) and lithium chloride (LiCl) for 7 days, hESCs adopted cobble-stone epithelial phenotype (hESC-derived epithelial cells (ES-ECs)) and expressed cytokeratin 14. Compared with ALCs and oral epithelial cells (OE), ES-ECs expressed amelogenesis-associated genes similar to ALCs. ES-ECs were compared with human fetal skin epithelium, human fetal oral buccal mucosal epithelial cells and human ALCs for their expression pattern of cytokeratins as well. ALCs had relatively high expression levels of cytokeratin 76, which was also found to be upregulated in ES-ECs. Based on the present study, with the similarity of gene expression with ALCs, ES-ECs are a promising potential cell source for regeneration, which are not available in erupted human teeth for regeneration of enamel.
Ameloblasts
;
physiology
;
Amelogenesis
;
genetics
;
Amelogenin
;
analysis
;
Bone Morphogenetic Protein 4
;
pharmacology
;
Cell Culture Techniques
;
Cell Differentiation
;
drug effects
;
Cell Line
;
Cell Lineage
;
Embryonic Stem Cells
;
drug effects
;
physiology
;
Epithelial Cells
;
drug effects
;
physiology
;
Fibroblast Growth Factor 8
;
analysis
;
Hedgehog Proteins
;
analysis
;
Homeodomain Proteins
;
analysis
;
Humans
;
Keratins
;
analysis
;
classification
;
Lithium Chloride
;
pharmacology
;
MSX1 Transcription Factor
;
analysis
;
Mouth Mucosa
;
cytology
;
Phenotype
;
Regeneration
;
physiology
;
Skin
;
cytology
;
Transcription Factors
;
analysis
;
Tretinoin
;
pharmacology
9.Neurotoxicity Screening in a Multipotent Neural Stem Cell Line Established from the Mouse Brain.
Yong Soo CHOI ; Min Cheol LEE ; Hyung Seok KIM ; Kyung Hwa LEE ; Yeoung Geol PARK ; Hyun Kyung KIM ; Han Seong JEONG ; Myeong Kyu KIM ; Young Jong WOO ; Seung Up KIM ; Jae Kyu RYU ; Hyun Beom CHOI
Journal of Korean Medical Science 2010;25(3):440-448
Neural stem cells (NSCs) have mainly been applied to neurodegeneration in some medically intractable neurologic diseases. In this study, we established a novel NSC line and investigated the cytotoxic responses of NSCs to exogenous neurotoxicants, glutamates and reactive oxygen species (ROS). A multipotent NSC line, B2A1 cells, was established from long-term primary cultures of oligodendrocyte-enriched cells from an adult BALB/c mouse brain. B2A1 cells could be differentiated into neuronal, astrocytic and oligodendroglial lineages. The cells also expressed genotypic mRNA messages for both neural progenitor cells and differentiated neuronoglial cells. B2A1 cells treated with hydrogen peroxide and L-buthionine-(S,R)-sulfoximine underwent 30-40% cell death, while B2A1 cells treated with glutamate and kainate showed 25-35% cell death. Cytopathologic changes consisting of swollen cell bodies, loss of cytoplasmic processes, and nuclear chromatin disintegration, developed after exposure to both ROS and excitotoxic chemicals. These results suggest that B2A1 cells may be useful in the study of NSC biology and may constitute an effective neurotoxicity screening system for ROS and excitotoxic chemicals.
Animals
;
Brain/*cytology
;
Buthionine Sulfoximine/pharmacology
;
Cell Differentiation
;
Cell Line
;
Cell Lineage
;
Cytokines/pharmacology
;
Enzyme Inhibitors/pharmacology
;
Excitatory Amino Acid Agonists/pharmacology
;
Glutamic Acid/pharmacology
;
Humans
;
Hydrogen Peroxide/pharmacology
;
Intercellular Signaling Peptides and Proteins/pharmacology
;
Kainic Acid/pharmacology
;
Mice
;
Mice, Inbred BALB C
;
Multipotent Stem Cells/cytology/*drug effects/physiology
;
Neuroglia/cytology/drug effects/physiology
;
Neurons/cytology/*drug effects/physiology
;
Neurotoxins/*pharmacology
;
Oxidants/pharmacology
;
Phenotype
;
Reactive Oxygen Species/metabolism
10.Capsaicin promotes the development of burst-forming nits-erythroid (BFU-E) from mouse bone marrow cells.
Seong Ae LEE ; Young Shin RYU ; Hyung Im CHOI ; In Seob HAN
Experimental & Molecular Medicine 2007;39(3):278-283
Capsaicin, the pungent component of chilli peppers, is known to induce mediators of hematopoiesis. We investigated the effect of capsaicin on hematopoiesis in mouse progenitor cells. Treatment of mouse bone marrow cells with capsaicin induced the formation of colony of burst-forming units-erythroid (BFU-E). We also found that the number of erythropoietin receptor (EpoR)-positive cells was increased by capsaicin. To clarify the effect of capsaicin on erythroid lineage, BFU-E colonies were separated from non-BFU-E colonies by colony-picking after in vitro culture of mouse bone marrow cells. Quantitative RT-PCR analysis revealed that capsaicin stimulated the expression of the erythroid-specific genes encoding EpoR, glycophorin A (GPA), beta-globin (Hbb-b1), GATA-1, PU.1, nuclear factor erythroid-derived 2 (NF-E2), and Kruppel-like factor 1 (KLF1) in the BFU-E colonies. Furthermore, capsaicin could effectively stimulate the transfected GATA-1 promoter in K562 cells. GATA-1 is known as an essential transcription factor for the development of erythroid cells. Our results show that development of the erythroid lineage from bone marrow cells can be induced by treatment with capsaicin, and that GATA-1 seems to play a role in this induced erythroid maturation.
Animals
;
Bone Marrow Cells/*cytology/drug effects/metabolism
;
Capsaicin/*pharmacology
;
Cell Lineage
;
Cells, Cultured
;
Colony-Forming Units Assay
;
Erythroid Cells/*cytology
;
GATA1 Transcription Factor/genetics/metabolism
;
Hematopoiesis
;
Hematopoietic Stem Cells/*cytology/drug effects/metabolism
;
Male
;
Mice
;
Mice, Inbred C57BL
;
Promoter Regions, Genetic
;
Receptors, Erythropoietin/metabolism